Search in:

Advanced search

Pharmacogenomics and Personalized Medicine Volume 10, 2017 - Issue

Submit an article Journal homepage

Open access

110

Views

CrossRef citations to date

Altmetric

Original Research

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

Paul Y Takahashi1 Division of Primary Care Internal Medicine, Department of MedicineCorrespondence[email protected]

Euijung Ryu2 Department of Health Sciences Research

Jyotishman Pathak2 Department of Health Sciences Research

Gregory D Jenkins2 Department of Health Sciences Research

Anthony Batzler2 Department of Health Sciences Research

Matthew A Hathcock2 Department of Health Sciences Research

John Logan Black3 Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Janet E Olson2 Department of Health Sciences Research

James R Cerhan2 Department of Health Sciences Research

Suzette J Bielinski2 Department of Health Sciences Research

show all

Pages 39-47 | Published online: 14 Feb 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MannesseCKDerkxFHde RidderMAMan in ‘t VeldAJvan der CammenTJContribution of adverse drug reactions to hospital admission of older patientsAge Ageing2000291353910690693
PubMed Web of Science ®Google Scholar
ZangerUMSchwabMCytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variationPharmacol Ther2013138110314123333322
PubMed Web of Science ®Google Scholar
RuanoGSzarekBLVillagraDLength of psychiatric hospitalization is correlated with CYP2D6 functional status in inpatients with major depressive disorderBiomark Med20137342943923734807
PubMed Web of Science ®Google Scholar
KroppSLichtinghagenRWintersteinKSchlimmeJSchneiderUCytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatryClin Lab2006525–623724016812949
PubMed Web of Science ®Google Scholar
YepTDevineBA cost utility analysis of CYP2D6 pharmacogenetic guided dosing versus standard dosing of risperidone for treatment of schizophreniaValue Health2014173A217
Web of Science ®Google Scholar
KellyLERiederMvan den AnkerJMore codeine fatalities after tonsillectomy in North American childrenPediatrics20121295e1343e134722492761
PubMed Web of Science ®Google Scholar
RiederMJCarletonBPharmacogenomics and adverse drug reactions in childrenFront Genet201457824795743
PubMed Web of Science ®Google Scholar
SamerCFLorenziniKIRollasonVDaaliYDesmeulesJAApplications of CYP450 testing in the clinical settingMol Diagn Ther201317316518423588782
PubMed Web of Science ®Google Scholar
GoetzMPKnoxSKSumanVJThe impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenBreast Cancer Res Treat2007101111312117115111
PubMed Web of Science ®Google Scholar
OlsonJERyuEJohnsonKJThe Mayo Clinic Biobank: a building block for individualized medicineMayo Clin Proc201388995296224001487
PubMed Web of Science ®Google Scholar
BielinskiSJOlsonJEPathakJPreemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocolMayo Clin Proc2014891253324388019
PubMed Web of Science ®Google Scholar
HaasLRTakahashiPYShahNDRisk-stratification methods for identifying patients for care coordinationAm J Manag Care201319972573224304255
PubMed Web of Science ®Google Scholar
WeinerJPStarfieldBHSteinwachsDMMumfordLMDevelopment and application of a population-oriented measure of ambulatory care case-mixMed Care19912954524721902278
PubMed Web of Science ®Google Scholar
BlackJL3rdWalkerDLO’KaneDJHarmandayanMFrequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype predictionDrug Metab Dispos201240111111922004686
PubMed Web of Science ®Google Scholar
KramerWEWalkerDLO’KaneDJCYP2D6: novel genomic structures and allelesPharmacogenet Genomics2009191081382219741566
PubMed Web of Science ®Google Scholar
JiYSkierkaJMBlommelJHPreemptive pharmacogenomic testing for precision medicine: a comprehensive analysis of five actionable pharmacogenomic genes using next-generation DNA sequencing and a customized CYP2D6 genotyping cascadeJ Mol Diagn201618343844526947514
PubMed Web of Science ®Google Scholar
CraneSJTungEEHansonGJChaSChaudhryRTakahashiPYUse of an electronic administrative database to identify older community dwelling adults at high-risk for hospitalization or emergency department visits: the elders risk assessment indexBMC Health Serv Res20101033821144042
PubMed Web of Science ®Google Scholar
NaessensJMStroebelRJFinnieDMEffect of multiple chronic conditions among working-age adultsAm J Manag Care201117211812221473661
PubMed Web of Science ®Google Scholar
KhalighiBWuYFanWQCYP2D6 genetic information-guided metoprolol use in a cardiology clinic: a perspective studyCardiology2014128Suppl 1159
Google Scholar
Penas-LledoEMLlerenaACYP2D6 genetic polymorphism and psychiatry patients’ hospitalization periodBiomark Med20137691591624266825
PubMed Web of Science ®Google Scholar
ShordSSCavallariLHGaoWThe pharmacokinetics of codeine and its metabolites in blacks with sickle cell diseaseEur J Clin Pharmacol200965765165819357842
PubMed Web of Science ®Google Scholar
HamelinBATurgeonJValleeFBelangerPMPaquetFLeBelMThe disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquinClin Pharmacol Ther19966055125218941024
PubMed Web of Science ®Google Scholar
Penas-LledoEGuillaumeSNaranjoMEA combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstancesPharmacogenomics J201515217217625113522
PubMed Web of Science ®Google Scholar
KirchheinerJBrosenKDahlMLCYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosagesActa Psychiatr Scand2001104317319211531654
PubMed Web of Science ®Google Scholar
TerraSGPaulyDFLeeCRBeta-adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureClin Pharmacol Ther200577312713715735607
PubMed Web of Science ®Google Scholar
St SauverJLGrossardtBRLeibsonCLYawnBPMeltonLJ3rdRoccaWAGeneralizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology ProjectMayo Clin Proc201287215116022305027
PubMed Web of Science ®Google Scholar
HeimMHMeyerUAEvolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6Genomics199214149581358797
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date